| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |